Quinoline, (1,1-dimethylethyl)-
Common Name: |
Quinoline, (1,1-dimethylethyl)- |
IUPAC Name: |
5-tert-butylquinoline |
Molecular Formula: |
C13H15N |
SMILES: |
CC(C)(C)C1=C2C=CC=NC2=CC=C1 |
Inchi: |
1S/C13H15N/c1-13(2,3)11-7-4-8-12-10(11)6-5-9-14-12/h4-9H,1-3H3 |
Inchi Key: |
CWVYYJOLOZEZOF-UHFFFAOYSA-N |
Cas No: |
61702-91-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
185.26 |
Mass (g/mol) |
185.12 |
Molar Refractivity |
61.01 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
2 |
TPSA |
12.89 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
10 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
286.00 to 287.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.31 |
LogP |
3.532 |
iLOGP |
2.50 |
XLOGP3 |
3.86 |
WLOGP |
3.53 |
MLOGP |
2.99 |
ESOL Log S |
-3.88 |
ESOL Solubility (mg/ml) |
0.024 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.83 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-4.91 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.69 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.867 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.372 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
1 |
OCT2 inhibitor |
0 |